Aging Overview

External factors

External factors: OH-TAM
Aging type: Accelerate
Aging characteristic:
Category: Other
Phenotype: Breast cancer
Experimental category: L
Tissue type: --
Cell name: Breast cancer cell
PMID: 20116857
Experiment: Flow cytometry//SA-β-gal activity assay//BrdU assay
Description: As previously described [29,30], after 48 h, OH-TAM significantly increased the percentage of cells in the G0/G1 phase for both ERa(+) cell lines (MCF-7, ZR-75-1) while no modification of cell cycle distribution was observed in either of the ERa negative cell lines (MDA-MB231, SKBR-3). Interestingly, Fc-OH-TAM affected cell cycle distribution differently from OH-TAM. In ERa(+) cells, 1μM of Fc-OH-TAM first increased the percentage of cells in the S phase at 24 h, and this increase was then followed by an arrest in G0/G1 at 48 h. Fc-OH-TAM significantly increased the percentage of BrdU-positive cells (48.09%) (in the S phase) compared to what is observed for non-treated cells or for cells treated with OH-TAM (35.63%), thus indicating a cell cycle progression from G0/G1 to S phase. Next, pulse/chase experiments were performed as follows: after the 2 h incubation period in the presence of BrdU, cells were washed, left to recover for 24 h, and then analyzed.OH-TAM increased the percentage of SA-βgalactosidase cells in ERa(+) cells but not in ERa() cells, indicating that G0/G1 cell cycle arrest was associated with senescence induction in MCF-7 cells treated with OH-TAM. Interestingly, FcOH-TAM treatment increased SA-β-galactosidase staining in both cell lines (MCF-7 and MDA-MB-231).


Regulatory pathway: --
R-EF-Pathway: --
Pathway experiment: --
Pathway description: --


Aging network

Annotation:

The green line represents Upregulation.

The purple line represents Downregulation.

The orange line represents Activation.

The yellow line represents Inhibition.

The gray line represents Unclear.